227 related articles for article (PubMed ID: 26174002)
1. Morphologic analysis of false negative SurePath® slides using Focalpoint™ GS computer-assisted cervical screening technology: An Australian experience.
Bowditch RC; Clarke JM; Baird PJ; Greenberg ML
Diagn Cytopathol; 2015 Nov; 43(11):870-8. PubMed ID: 26174002
[TBL] [Abstract][Full Text] [Related]
2. Results of an Australian trial using SurePath liquid-based cervical cytology with FocalPoint computer-assisted screening technology.
Bowditch RC; Clarke JM; Baird PJ; Greenberg ML
Diagn Cytopathol; 2012 Dec; 40(12):1093-9. PubMed ID: 22045553
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
4. A retrospective validation of the FocalPoint GS slide profiler NFR technology by analysis of interval disease outcomes compared with manual cytology.
Nuttall DS; Hillier S; Clayton HR; Savage AJ; Martin CM; O'Leary JJ
Cancer Cytopathol; 2019 Apr; 127(4):240-246. PubMed ID: 30825407
[TBL] [Abstract][Full Text] [Related]
5. Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices.
Rinas AC; Mittman BW; Le LV; Hartmann K; Cayless J; Singh HK
Acta Cytol; 2006; 50(1):55-62. PubMed ID: 16514841
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
[TBL] [Abstract][Full Text] [Related]
7. Cytology and curetting diagnosis of endocervical adenocarcinoma.
Bruehl FK; Dyhdalo KS; Hou Y; Clapacs E; Przybycin CG; Reynolds JP
J Am Soc Cytopathol; 2020; 9(6):556-562. PubMed ID: 32624383
[TBL] [Abstract][Full Text] [Related]
8. The interpretation of high-grade squamous intraepithelial lesion on anal cytology: a comparative analysis with the cervical Papanicolaou test.
Patel AP; Schatz-Siemers NF; Dilcher TL; Goyal A
J Am Soc Cytopathol; 2020; 9(6):540-549. PubMed ID: 32800528
[TBL] [Abstract][Full Text] [Related]
9. The pathological outcome of ThinPrep Pap tests diagnosed as glandular cell abnormalities alone versus combined glandular and squamous abnormalities.
Harbhajanka A; Chahar S; Michael CW
Diagn Cytopathol; 2019 Feb; 47(2):88-93. PubMed ID: 30451396
[TBL] [Abstract][Full Text] [Related]
10. BD focalpoint slide profiler performance with atypical glandular cells on SurePath Papanicolaou smears.
Chute DJ; Lim H; Kong CS
Cancer Cytopathol; 2010 Apr; 118(2):68-74. PubMed ID: 20209621
[TBL] [Abstract][Full Text] [Related]
11. Novel techniques for morphometric and geometrical analysis in squamous intraepithelial lesions on cervical smears.
Tsiambas E; Riziotis C; Mavrikos I; Armatas E; Patsouris E
J BUON; 2017; 22(4):1081-1083. PubMed ID: 28952232
[No Abstract] [Full Text] [Related]
12. A Multi-Institutional Feasibility Study on the Use of Automated Screening Systems for Quality Control Rescreening of Cervical Cytology.
Sugiyama Y; Sasaki H; Komatsu K; Yabushita R; Oda M; Yanoh K; Ueda M; Itamochi H; Okugawa K; Fujita H; Tase T; Nakatani E; Moriya T
Acta Cytol; 2016; 60(5):451-457. PubMed ID: 27673689
[TBL] [Abstract][Full Text] [Related]
13. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
14. Whole-Slide Imaging of Pap Cellblock Preparations Is a Potentially Valid Screening Method.
Tawfik O; Davis M; Dillon S; Tawfik L; Diaz FJ; Amin K; Fan F
Acta Cytol; 2015; 59(2):187-200. PubMed ID: 25967603
[TBL] [Abstract][Full Text] [Related]
15. Cytomorphologic Features of Gastric-Type Endocervical Adenocarcinoma in Liquid-Based Preparations.
Schwock J; Starova B; Khan ZF; Mirkovic J; Parra-Herran C; Ko HM; Rouzbahman M; Ghorab Z
Acta Cytol; 2021; 65(1):56-66. PubMed ID: 33152741
[TBL] [Abstract][Full Text] [Related]
16. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.
Guo M; Shlyakhova N; Khanna A; Tinnirello AA; Schmeler KM; Hwang J; Sturgis EM; Stewart J
J Am Soc Cytopathol; 2021; 10(4):399-405. PubMed ID: 33967024
[TBL] [Abstract][Full Text] [Related]
17. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
Ge Y; Christensen P; Luna E; Armylagos D; Schwartz MR; Mody DR
Cancer Cytopathol; 2017 Aug; 125(8):652-657. PubMed ID: 28574670
[TBL] [Abstract][Full Text] [Related]
18. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of endocervical curettage for detecting dysplastic lesions in women with atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesion (LSIL) Papanicolaou smears.
Poomtavorn Y; Suwannarurk K; Thaweekul Y; Maireang K
Asian Pac J Cancer Prev; 2014; 15(8):3461-4. PubMed ID: 24870740
[TBL] [Abstract][Full Text] [Related]
20. Endocervical glandular involvement is associated with an increased detection rate of high-grade squamous intraepithelial lesions on the Papanicolaou test.
Jones R; Dale F; Fite JJ; Cowan ML; Williamson B; DeLuca J; VandenBussche CJ
J Am Soc Cytopathol; 2020; 9(3):137-145. PubMed ID: 32147423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
